Related Experiment Videos
Comprehensive management of headache and depression
1Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA 19144, USA.
Cephalalgia : an International Journal of Headache
|April 9, 1998
Summary
Treating comorbid migraine and depression requires accurate diagnosis and tailored interventions. Antidepressants are key, with selective serotonin reuptake inhibitors offering a good balance of efficacy and tolerability for depression.
Area of Science:
- Neurology
- Psychiatry
Background:
- Migraine is a common episodic headache disorder.
- Comorbid migraine and depression present unique treatment challenges and opportunities.
Purpose of the Study:
- To outline effective treatment strategies for patients experiencing both migraine and depression.
- To highlight the importance of accurate diagnosis and patient education.
Main Methods:
- Review of therapeutic interventions for comorbid migraine and depression.
- Discussion of behavioral interventions, psychotherapy, and pharmacotherapy.
Main Results:
- Accurate diagnosis and patient explanation are foundational for effective treatment.
- Behavioral interventions (regular schedule, sleep, exercise, smoking cessation) are beneficial.
- Antidepressant therapy is often necessary for depression, independent of migraine frequency.
- Tricyclic antidepressants may offer migraine benefits, while SSRIs are effective for depression with fewer side effects.
- Divalproex sodium is recommended for migraine with epilepsy or bipolar disorder.
- Combination therapies, including antidepressants and beta-blockers, can be used for refractory cases.
Conclusions:
- Integrated treatment approaches are essential for managing comorbid migraine and depression.
- Pharmacological and non-pharmacological strategies should be individualized.
- Further research into antidepressant mechanisms for headache prophylaxis is warranted.